Various complications like recurrent myocardial infarction, mechanical complications, and scar-related ventricular arrhythmias may have contributed to mortality, thus nullifying the beneficial effect of SGLT2 inhibitors on mortality during this period[35]. The gene discussed is SLC5A2; the disease is Ventricular arrhythmia.